Sector Gamma As Astrazeneca PLC Transaction History

Sector Gamma As

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $7.35 Million - $8.82 Million	-124,000 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$55.72 - $67.12 $6.91 Million - $8.32 Million	124,000 New	124,000 $8.23 Million
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $6.74 Million - $7.59 Million	-182,905 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$34.76 - $39.72 $3.11 Million - $3.56 Million	89,530 Added 95.88%	182,905 $7.24 Million
Q3 2018 Nov 08, 2018	SELL	$34.76 - $39.72 $24.6 Million - $28.1 Million	-707,213 Reduced 88.34%	93,375 $3.7 Million
Q2 2018 Aug 02, 2018	SELL	$34.55 - $37.05 $188,193 - $201,811	-5,447 Reduced 0.68%	800,588 $28.1 Million
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $2.99 Million - $3.32 Million	-90,736 Reduced 10.12%	806,035 $28.2 Million
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $5.01 Million - $5.43 Million	156,100 Added 21.08%	896,771 $31.1 Million
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $21.4 Million - $25.2 Million	740,671	740,671 $25.1 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.